Cogent Biosciences (COGT) Amortizatization of Intangibles (2017 - 2026)

Cogent Biosciences (COGT) recorded quarterly Amortizatization of Intangibles of $1.2 million in Q1 2026, up 158.77% quarter-over-quarter from $456000.0 in Q4 2025, and up 136.95% on a YoY basis from $498000.0 in Q1 2025.

Cogent Biosciences (COGT) Amortizatization of Intangibles (2017 - 2026) Analysis & Trends

Cogent Biosciences' Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $1.2 million for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles rose 136.95% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $2.6 million (up 36.85% YoY), while the FY2025 annual figure was $2.0 million, up 3.21% from the prior year.
  • Amortizatization of Intangibles was $1.2 million for Q1 2026 at Cogent Biosciences, up from $456000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $6.2 million in Q3 2024 to a low of -$3.1 million in Q4 2024.
  • Historically, Amortizatization of Intangibles has averaged $470529.4 across 5 years, with a median of $491000.0 in 2022.
  • Biggest YoY gain for Amortizatization of Intangibles was 2162.77% in 2024; the steepest drop was 1688.78% in 2024.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $1.2 million in 2022, then slumped by 83.42% to $196000.0 in 2023, then plunged by 1688.78% to -$3.1 million in 2024, then jumped by 114.64% to $456000.0 in 2025, then surged by 158.77% to $1.2 million in 2026.
  • The last three Amortizatization of Intangibles figures came in at $1.2 million (Q1 2026), $456000.0 (Q4 2025), and $506000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 13,267.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Cogent Biosciences 5.09 Bn 4.22 Bn - 1.18 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.18 Mn
Mar 31, 2026 1.18 Mn
Dec 31, 2025 456,000.00
Dec 31, 2025 456,000.00
Sep 30, 2025 506,000.00
Sep 30, 2025 506,000.00
Jun 30, 2025 502,000.00
Jun 30, 2025 502,000.00
Mar 31, 2025 498,000.00
Mar 31, 2025 498,000.00
Dec 31, 2024 -3.11 Mn
Dec 31, 2024 -3.11 Mn
Sep 30, 2024 6.20 Mn
Sep 30, 2024 6.20 Mn
Jun 30, 2024 -1.65 Mn
Jun 30, 2024 -1.65 Mn
Mar 31, 2024 467,000.00
Mar 31, 2024 467,000.00
Dec 31, 2023 196,000.00
Dec 31, 2023 196,000.00